Showing posts with label progesterone. Show all posts
Showing posts with label progesterone. Show all posts

Thursday, 28 August 2025

A Study of Elevated Progesterone Level and Its Consequences on In-vitro Fertilisation (IVF) Outcomes | Chapter 4 | Medical Science: Recent Advances and Applications Vol. 9

 

Background: The embryo-endometrium dialogue remains incompletely understood. During conventional in vitro fertilisation cycles, progesterone elevation on the day of human chorionic gonadotropin administration refers to rising progesterone levels in the absence of either premature or a luteinizing hormone surge. Most research has reported that elevated progesterone had an adverse impact on the endometrial environment of fresh cycles, leading to a decrease in pregnancy rates. High progesterone levels on the day of Human Chorionic Gonadotropin trigger induce advanced endometrial histological maturation and differential endometrial gene expression, which lead to implantation failure.

 

Aim: The aim of the study is to investigate the impact of elevated progesterone levels on the clinical outcomes of in vitro fertilisation.

 

Methods: The current study was undertaken at Swagat Hospital and Research Centre, Bongaigaon, Assam (India). Fifty patients undergoing in vitro fertilisation (IVF) were selected for the study. Baseline estimation of follicle-stimulating hormone (FSH), luteinizing hormone (LH), anti-Mullerian hormone (AMH), (estrogen) E2 and (transvaginal sonography) TVS was done. The patients were grouped on the basis of their progesterone levels on the day of hCG trigger, with the cutoff for defining premature progesterone rise being (progesterone) P4≥ 3ng/ml. Final oocyte maturation was induced with hCG. Oocyte retrieval was performed 34-36 h after hCG. Two to three embryos of the day 3 cleavage stage were transferred under TVS guidance. The parameters obtained from each cycle were recorded. Statistical analysis was performed. A probability (P) value <0.05 was considered statistically significant. A sonographic confirmation of pregnancy was performed 2 weeks after a β-hCG positive. Statistical analysis was conducted using SPSS v23.0, with the Chi-square test for categorical data, ANOVA for quantitative variables, and significance set at P<0.05.

 

Results: On dividing the patients into two groups based on the cut-off of P4 as 3ng/ml, it was observed that the no of cases that conceived was significantly higher in the subjects whose P4 level was less than or equal to 3ng/ml than in the subjects whose P4 level was more than 3ng/ml.

 

Conclusions: The present study showed an adverse relationship between higher circulating serum concentration of P4 and clinical pregnancy rate. Elevated P4 level just before trigger is a reflection of endometrial maturity that can cause disparity between endometrial and embryonic ageing and therefore hamper implantation or cause failure in assisted reproductive technology (ART).

 

Author(s) Details

Sankar Kumar Das
Department of Obstetrics and Gynecology, Swagta Hospital and Research Center, Bongaigaon Assam, India and Department of Obstetrics and Gynecology, Gauhati Medical College and Hospital, Guwahati, Assam, India.

 

Priyanka Roy
Department of Obstetrics and Gynecology, Swagta Hospital and Research Center, Bongaigaon Assam, India and Department of Obstetrics, Assam Medical College and Hospital, Dibrugarh, Assam, India.

 

Krishna Kalita
Department of Obstetrics and Gynecology, Swagta Hospital and Research Center, Bongaigaon Assam, India and Department of Obstetrics and Gynecology, Assam Agricultural University, Jorhat, Assam, India.

 

Please see the book here:- https://doi.org/10.9734/bpi/msraa/v9/5481

Friday, 12 February 2021

Advanced Study on Salivary Progesterone as a Biomarker in Pregnancy | Chapter 2 | Current Advances in Chemistry and Biochemistry Vol. 1

Progesterone is considered a hormone for pregnancy. At the end of labor, progesterone was measured in the saliva of pregnant females. During the last two weeks before the planned delivery date and 2 days after delivery, samples were collected twice a day (morning and afternoon). Using commercial ELISA kits, analysis was performed after basic freezing, thawing and centrifugation of the samples. It appeared that the progesterone level was in a steady state during the time before delivery, until around 2 days prior to delivery, at which point a rapid decrease could be observed. The amounts decreased to non-pregnant values again immediately after delivery. Two separate ELISA kits were used for comparative purposes and tested for suitability. Furthermore, the applicability and usefulness of the additional salivary estriol determination was investigated in a preliminary experiment. In conclusion, salivary progesterone can be used in pregnant women as an indication of imminent delivery. An additional parameter supporting the efficacy of salivary progesterone could be salivary estriol. Estriol is also considered to provide information about the well-being of the fetus and is said to be a catalyst for delivery. As a consequence, its study can also help to predict the time of delivery, to take optional steps in the case of premature delivery or difficult pregnancies, and to provide information on fetal health. In order to statistically test the results of this study by adding more participants, both having normal deliveries and complicated pregnancies, additional research is required. The findings of this study are intended only to suggest the possibility of creating a home-use biosensor that would contribute significantly to the health of mothers and newborns.

Author (s) Details

Dr. P. Meulenberg Eline
ELTI Support VOF, Ambachtsweg 5, 6581 AX Malden, The Netherlands.

View Book :- https://stm.bookpi.org/CACB-V1/issue/view/12